Governor Juan F. Luis Hospital & Medical Center

Governor Juan F. Luis Hospital & Medical Center was paid $15.37M by Medicaid between Jan 2018 and Nov 2024, across 166 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 34% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	15,353	$1.37M
2019	38,242	$2.59M
2020	34,741	$2.04M
2021	45,858	$2.63M
2022	54,146	$2.53M
2023	53,792	$2.61M
2024incomplete	34,400	$1.61M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
36415	Collection of venous blood by venipuncture	34%	28,378	23,671	$5.25M
99281	Emergency department visit for the evaluation and management, self-limited or minor	7.1%	4,803	4,401	$1.09M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	6.5%	7,949	6,721	$1.00M
99282	Emergency department visit for the evaluation and management, low to moderate severity	5.7%	8,333	7,481	$872K
77063	Screening digital breast tomosynthesis, bilateral	5.6%	2,679	2,600	$859K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	3.2%	1,776	1,632	$488K
81003		3.1%	12,316	11,175	$483K
71046	Radiologic examination, chest; 2 views	3.0%	5,580	5,202	$469K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	2.8%	3,677	3,355	$424K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.7%	16,843	14,978	$416K
99218		2.4%	1,178	1,046	$372K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.9%	2,318	2,201	$293K

154 more codes

Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	1.3%	1,867	$202K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.3%	2,614	$197K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	1.2%	991	$178K
70450	Computed tomography, head or brain; without contrast material	1.1%	2,715	$166K
80053	Comprehensive metabolic panel	1.0%	15,791	$161K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.0%	7,520	$155K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,505	$152K
76830	Ultrasound, transvaginal	<1%	557	$151K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,504	$140K
J3490	Unclassified drugs	<1%	1,979	$127K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	1,306	$106K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,119	$99K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	472	$95K
73630		<1%	726	$90K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	342	$85K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	303	$83K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,341	$76K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	5,377	$75K
99284	Emergency room visit (serious)	<1%	5,289	$63K
G0378	Hospital observation service, per hour	<1%	1,788	$60K
76801		<1%	202	$56K
73030		<1%	292	$41K
73562		<1%	214	$39K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,518	$38K
87088		<1%	7,625	$36K
73130		<1%	257	$32K
71045	Radiologic examination, chest; single view	<1%	1,629	$31K
76641		<1%	104	$29K
72100		<1%	158	$28K
82948		<1%	2,803	$27K
J1170	Injection, hydromorphone, up to 4 mg	<1%	147	$23K
73610		<1%	201	$23K
87070		<1%	780	$21K
81001		<1%	2,801	$20K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	118	$19K
73110		<1%	105	$19K
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	97	$17K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	577	$17K
81025		<1%	2,493	$17K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	331	$16K
77065	Tomosynthesis, mammo	<1%	90	$16K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	18,510	$16K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	1,806	$16K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,183	$15K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,901	$15K
70486		<1%	56	$13K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,189	$12K
85610		<1%	3,748	$12K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,424	$11K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,961	$11K
84702		<1%	2,634	$11K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	3,768	$10K
59025	Fetal non-stress test	<1%	689	$10K
S0028	Injection, famotidine, 20 mg	<1%	64	$9K
74018		<1%	137	$8K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	304	$8K
J7510	Prednisolone oral, per 5 mg	<1%	47	$8K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	707	$8K
71250		<1%	25	$7K
72125	Computed tomography, cervical spine; without contrast material	<1%	530	$7K
96361	Intravenous infusion, hydration; each additional hour	<1%	110	$6K
85027		<1%	2,302	$6K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,498	$5K
J2704	Injection, propofol, 10 mg	<1%	1,333	$5K
84439		<1%	1,049	$5K
76770		<1%	14	$5K
71275	Computed tomographic angiography, chest, with contrast material	<1%	363	$5K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	76	$5K
90714		<1%	660	$5K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	16	$5K
93971		<1%	29	$4K
96376		<1%	924	$4K
77080		<1%	12	$4K
76536		<1%	12	$4K
86850		<1%	1,249	$3K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	1,395	$3K
80061	Lipid panel	<1%	3,628	$3K
82272		<1%	362	$2K
73060		<1%	16	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	856	$2K
87186		<1%	1,341	$2K
99285	Emergency room visit (most serious)	<1%	201	$2K
G0379	Direct admission of patient for hospital observation care	<1%	654	$2K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	487	$2K
86901		<1%	232	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	3,912	$2K
J0690	Injection, cefazolin sodium, 500 mg	<1%	469	$2K
73590		<1%	13	$2K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	14	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	133	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	316	$1K
90715		<1%	210	$1K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	160	$1K
82553		<1%	2,286	$960.15
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	965	$864.86
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	379	$791.63
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	839	$788.10
87485		<1%	94	$788.10
J2060	Injection, lorazepam, 2 mg	<1%	177	$773.08
C9113	Injection, pantoprazole sodium, per vial	<1%	132	$764.24
84484		<1%	4,250	$617.38
82570		<1%	354	$509.65
86140		<1%	519	$506.50
84436		<1%	52	$441.76
82784		<1%	14	$422.07
83690		<1%	3,437	$414.64
87210		<1%	19	$388.75
J1815	Injection, insulin, per 5 units	<1%	61	$375.50
12001		<1%	13	$375.50
82550		<1%	2,438	$225.28
83880		<1%	581	$165.61
85730		<1%	2,271	$140.60
84156		<1%	255	$129.85
86904		<1%	189	$124.20
83615		<1%	905	$97.20
83735		<1%	777	$66.49
84450		<1%	431	$46.40
83970		<1%	12	$38.80
88312		<1%	85	$24.40
80306		<1%	1,203	$23.80
85652		<1%	1,001	$22.80
82728		<1%	101	$17.20
87040		<1%	155	$16.60
84100		<1%	129	$12.80
82150		<1%	318	$11.60
84550		<1%	226	$8.40
86592		<1%	309	$6.00
A4208	Syringe with needle, sterile 3 cc, each	<1%	137	$6.00
A4209	Syringe with needle, sterile 5 cc or greater, each	<1%	106	$4.00
85007		<1%	299	$1.00
85018		0%	178	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	47	$0.00
85379		0%	345	$0.00
A4615	Cannula, nasal	0%	271	$0.00
86803		0%	13	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	12	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	48	$0.00
82607		0%	41	$0.00
83550		0%	43	$0.00
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	0%	18	$0.00
87340		0%	82	$0.00
87912		0%	94	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	28	$0.00
82043		0%	12	$0.00
82803		0%	18	$0.00
J3535	Drug administered through a metered dose inhaler	0%	14	$0.00
86703		0%	201	$0.00
85014		0%	178	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	30	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	26	$0.00
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	0%	28	$0.00
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	0%	52	$0.00
A7002	Tubing, used with suction pump, each	0%	15	$0.00
86038		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCALLISTE, GREGORY (CHIEF EXECUTIVE OFFICER)